His complaint named more than a dozen companies as defendants, including Sandoz Canada and GSK...But the court dismissed the case due to “the uncontroverted evidence that neither ranitidine nor NDMA are reliably associated with increased cancer risk,” GSK said in its statement...READ MORE ...